Skip to main content

Table 4 Clinical Outcomes in Patients with and without MPBF

From: Maldistribution of pulmonary blood flow in patients after the Fontan operation is associated with worse exercise capacity

  All patients With MPBF Without MPBF P value*
(n = 147) (n = 53) (n = 94)
 Follow-up time post CMR (year) 4.2 [2.1–8.4] 4.1 [1.7–9.1] 4.4 [2.4–8.9] 0.59
 Death 10 (7%) 4 (8%) 6 (6%) 0.70
 Death / listing for transplantation 14 (10%) 6 (11%) 8 (9%) 0.60
 Liver disease 50 (34%) 16 (30%) 34 (36%) 0.58
 Heart failure 35 (24%) 15 (29%) 20 (22%) 0.42
 Thrombus 28 (19%) 12 (22%) 16 (17%) 0.50
 Seizures 16 (11%) 6 (11%) 10 (11%) 0.90
 Stroke 26 (18%) 11 (21%) 15 (17) 0.50
 Protein-losing enteropathy 5 (3%) 1 (2%) 4 (4%) 0.40
 Atrial flutter post-Fontan 32 (22%) 11 (21%) 21 (22%) 0.90
  1. Abbreviations: MPBF maldistribution of pulmonary blood flow
  2. *Fisher exact test p-value for all variables except follow-up time (Mann-Whitney U Test)